Tissue microarrays in clinical urology – Technical considerations

References

• DeRisi J, Penland L, Brown PO, Bittner ML, Meltzer PS, Ray M, et al. Use of a cDNA microarray to analyse gene expression patterns in human cancer. Nat Genet 1996; 14: 457–60
   PubMed Web of Science ®Google Scholar
• Velculescu VE, Zhang L, Vogelstein B, Kinzler KW. Serial analysis of gene expression. Science 1995; 270: 484–7
   PubMed Web of Science ®Google Scholar
• Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, Leighton S, et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 1998; 4: 844–7
   PubMed Web of Science ®Google Scholar
• Slamon DJ, Leyland-Jones B, Shak S, Fuchs H, Paton V, Bajamonde A, et al. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med 2001; 344: 783–92
   PubMed Web of Science ®Google Scholar
• Battifora H. The multitumor (sausage) tissue block: novel method for immunohistochemical antibody testing. Lab Invest 1986; 55: 244–8
   PubMed Web of Science ®Google Scholar
• Theillet C. Full speed ahead for tumor screening. Nat Med 1998; 4: 767–8
   PubMed Web of Science ®Google Scholar
• Merseburger AS, Kuczyk MA, Serth J, Bokemeyer C, Young DY, Sun L, et al. Limitations of tissue microarrays in the evaluation of focal alterations of bcl-2 and p53 in whole mount derived prostate tissues. Oncol Rep 2003; 10: 223–8
   PubMed Web of Science ®Google Scholar
• Rubin MA, Dunn R, Strawderman M, Pienta KJ. Tissue microarray sampling strategy for prostate cancer biomarker analysis. Am J Surg Pathol 2002; 26: 1236–8
   PubMed Web of Science ®Google Scholar
• Nocito A, Kononen J, Kallioniemi OP, Sauter G. Tissue microarrays (TMAs) for high-throughput molecular pathology research. Int J Cancer 2001; 94: 1–5
   PubMed Web of Science ®Google Scholar
• Camp RL, Charrette LA, Rimm DL. Validation of tissue microarray technology in breast carcinoma. Lab Invest 2000; 80: 1943–9
   PubMed Web of Science ®Google Scholar
• Kallioniemi OP, Wagner U, Kononen J, Sauter G. Tissue microarray technology for high-throughput molecular profiling of cancer. Hum Mol Genet 2001; 10: 657–62
   PubMed Web of Science ®Google Scholar
• Hoos A, Cordon-Cardo C. Tissue microarray profiling of cancer specimens and cell lines: opportunities and limitations. Lab Invest 2001; 81: 1331–8
   PubMed Web of Science ®Google Scholar
• Henshall S. Tissue microarrays. J Mammary Gland Biol Neoplasia 2001; 8: 347–58
   Web of Science ®Google Scholar
• Packeisen J, Korsching E, Herbst H, Boecker W, Buerger H. Demystified tissue microarray technology. Mol Pathol 2003; 56: 198–204
   PubMedGoogle Scholar
• Theodorescu D, Broder SR, Boyd JC, Mills SE, Frierson HF, Jr. Cathepsin D and chromogranin A as predictors of long term disease specific survival after radical prostatectomy for localized carcinoma of the prostate. Cancer 1997; 80: 2109–19
   PubMed Web of Science ®Google Scholar
• Bucher, C, Tohorst, J, Kononen, J, Haas, P, Askaa, J, Godtfredsen, SE, et al. Automated, high-throughput tissue microarray analysis for assessing the significance of Her-2 involvement in breast cancer. J Clin Oncol 2000; Annual Meeting:2338.
   Google Scholar
• Kocher T, Zheng M, Bolli M, Simon R, Forster T, Schultz-Thater E, et al. Prognostic relevance of MAGE-A4 tumor antigen expression in transitional cell carcinoma of the urinary bladder: a tissue microarray study. Int J Cancer 2002; 100: 702–5
   PubMed Web of Science ®Google Scholar
• Simon R, Struckmann K, Schraml P, Wagner U, Forster T, Moch H, et al. Amplification pattern of 12q13-q15 genes (MDM2, CDK4, GLI) in urinary bladder cancer. Oncogene 2002; 21: 2476–83
   PubMed Web of Science ®Google Scholar
• Zaharieva BM, Simon R, Diener PA, Ackermann D, Maurer R, Alund G, et al. High-throughput tissue microarray analysis of 11q13 gene amplification (CCND1, FGF3, FGF4, EMS1) in urinary bladder cancer. J Pathol 2003; 201: 603–8
   PubMed Web of Science ®Google Scholar
• Visapaa H, Seligson D, Eeva M, Gaber F, Rao J, Belldegrun A, et al. 8q24 amplification in transitional cell carcinoma of bladder. Appl Immunohistochem Mol Morphol 2004; 11: 33–6
   Google Scholar
• Retz MM, Sidhu SS, Blaveri E, Kerr SC, Dolganov GM, Lehmann J, et al. CXCR4 expression reflects tumor progression and regulates motility of bladder cancer cells. Int J Cancer 2005; 114: 182–9
   PubMed Web of Science ®Google Scholar
• Ohlsson G, Moreira JM, Gromov P, Sauter G, Celis JE. Loss of expression of the adipocyte-type fatty acid-binding protein (A-FABP) is associated with progression of human urothelial carcinomas. Mol Cell Proteomics 2005; 4: 570–81
   PubMed Web of Science ®Google Scholar
• Richter J, Wagner U, Kononen J, Fijan A, Bruderer J, Schmid U, et al. High-throughput tissue microarray analysis of cyclin E gene amplification and overexpression in urinary bladder cancer. Am J Pathol 2000; 157: 787–94
   PubMed Web of Science ®Google Scholar
• Schraml P, Bucher C, Bissig H, Nocito A, Haas P, Wilber K, et al. Cyclin E overexpression and amplification in human tumours. J Pathol 2003; 200: 375–85
   PubMed Web of Science ®Google Scholar
• Halvorsen OJ, Haukaas SA, Akslen LA. Combined loss of PTEN and p27 expression is associated with tumor cell proliferation by Ki-67 and increased risk of recurrent disease in localized prostate cancer. Clin Cancer Res 2003; 9: 1474–9
   PubMed Web of Science ®Google Scholar
• Li R, Younes M, Frolov A, Wheeler TM, Scardino P, Ohori M, et al. Expression of neutral amino acid transporter ASCT2 in human prostate. Anticancer Res 2003; 23: 3413–18
   PubMed Web of Science ®Google Scholar
• Srivastava M, Bubendorf L, Srikantan V, Fossom L, Nolan L, Glasman M, et al. ANX7, a candidate tumor suppressor gene for prostate cancer. Proc Natl Acad Sci U S A 2001; 98: 4575–80
   PubMed Web of Science ®Google Scholar
• Jhavar S, Corbishley CM, Dearnaley D, Fisher C, Falconer A, Parker C, et al. Construction of tissue microarrays from prostate needle biopsy specimens. Br J Cancer 2005; 93: 478–82
   PubMed Web of Science ®Google Scholar
• National Cancer Institute, Center for Cancer Research. Available from:, , http://ccr.cancer.gov/tech%5Finitiatives/tarp.
   Google Scholar
• Prophet EB, Mills B, Arrington JB, Sobin HL. AFIP laboratory methods in histotechnology. American Registry of Pathology, Washington, DC 1992
   Google Scholar